Group One Trading’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $559 | Sell |
192
-348
| -64% | -$1.01K | ﹤0.01% | 1872 |
|
|
2025
Q1 | $1.33K | Hold |
540
| – | – | ﹤0.01% | 1714 |
|
|
2024
Q4 | $1.74K | Hold |
540
| – | – | ﹤0.01% | 1774 |
|
|
2024
Q3 | $1.39K | Hold |
540
| – | – | ﹤0.01% | 1489 |
|
|
2024
Q2 | $1.23K | Hold |
540
| – | – | ﹤0.01% | 1538 |
|
|
2024
Q1 | $1.73K | Hold |
540
| – | – | ﹤0.01% | 1515 |
|
|
2023
Q4 | $1.81K | Hold |
540
| – | – | ﹤0.01% | 1622 |
|
|
2023
Q3 | $1.84K | Hold |
540
| – | – | ﹤0.01% | 1636 |
|
|
2023
Q2 | $2.22K | Sell |
540
-2
| -0.4% | -$8 | ﹤0.01% | 1510 |
|
|
2023
Q1 | $4.7K | Sell |
542
-25
| -4% | -$217 | ﹤0.01% | 1449 |
|
|
2022
Q4 | $7.44K | Sell |
567
-331
| -37% | -$4.34K | ﹤0.01% | 1489 |
|
|
2022
Q3 | $15K | Sell |
898
-20
| -2% | -$334 | ﹤0.01% | 1498 |
|
|
2022
Q2 | $10K | Buy |
918
+5
| +0.5% | +$54 | ﹤0.01% | 1644 |
|
|
2022
Q1 | $20K | Sell |
913
-365
| -29% | -$8K | ﹤0.01% | 1622 |
|
|
2021
Q4 | $44K | Sell |
1,278
-420
| -25% | -$14.5K | ﹤0.01% | 1606 |
|
|
2021
Q3 | $104K | Buy |
1,698
+1,242
| +272% | +$76.1K | ﹤0.01% | 1336 |
|
|
2021
Q2 | $36K | Buy |
456
+84
| +23% | +$6.63K | ﹤0.01% | 1594 |
|
|
2021
Q1 | $21K | Buy |
372
+315
| +553% | +$17.8K | ﹤0.01% | 1540 |
|
|
2020
Q4 | $4K | Buy |
57
+50
| +714% | +$3.51K | ﹤0.01% | 1496 |
|
|
2020
Q3 | $1K | Sell |
7
-9
| -56% | -$1.29K | ﹤0.01% | 1454 |
|
|
2020
Q2 | $2K | Hold |
16
| – | – | ﹤0.01% | 1283 |
|
|
2020
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1273 |
|